Anupam Rasayan India Ltd. · NSE:ANURAS
Anupam Rasayan India — Q2 FY2023 Earnings Presentation
30 slides from Anupam Rasayan India's earnings presentation, Oct 28, 2022
Slide 1: Exchange filing cover letter: Investor Presentation
ANUPAM RASAYAN INDIA LTD. R ARILSLDSTX20221028072 Date: October 28, 2022 To, To, BSE Limited, National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Sr. General Manager Dalal Street, ‘Exchange Plaza’, C-1, Block-G, Mumbai -400001, India Bandra Kurla Complex SCRIP CODE: 543275 Bandra (Ea
Slide 2: Anupam Rasayan India Limited Investor Presentation Q2FY23
ANUPAM RASAYAN INDIA LIMITED INVESTOR PRESENTATION BSE: 543275 | NSE: ANURAS | ISIN: INE930P01018 Q2FY23 ©2020 – Anupam Rasayan India Limited, All Rights Reserved. October 2022
Slide 3: Tables of Contents
Tables of Contents FINANCIALS AND OPERATIONAL UPDATES Slide 03 OUR BUSINESS Slide 17 BOARD OF DIRECTORS Slide 26
Slide 4: Financials and Operational Updates
FINANCIALS AND OPERATIONAL UPDATES Quarterly Financial Highlights Slide 4 Managing Director’s message Slide 5 QIP & Capex Update Slide 10 Growth Drivers Slide 12
Slide 5: Quarterly Standalone Financial Highlights
FINANCIALS AND OPERATIONAL UPDATES Quarterly Standalone Financial Highlights Operating Revenue was EBITDA (Incl. Other Revenue) was PAT stood at ₹ 412 Mn., ₹ 3,107 Mn; Y-o-Y growth of 25% ₹ 898 Mn.; Y-o-Y growth of 29% Y-o-Y growth of 15% Cashflow From Operations stood Added 1 MNC customer in Added
Slide 6: Managing Director's Message
Managing Director’s Message Mr. Anand S Desai “I am delighted to inform you that our standalone business grew by 25% year on M A N A G I N G D I R E C TO R year to Rs. 310cr. EBITDA margins were consistent driven by inventory holding strategy. Cashflow from operations of the company for H1FY23 stood
Slide 7: Consolidated Profit & Loss Summary
QUARTERLY FINANCIALS Consolidated Profit & Loss Summary (All amounts are in ₹ Mn) Q2FY22 Q2FY23 INCOME Revenue from Operations 2,489 3,862 Other Income 62 (31) Total Revenue 2,552 3,831 Total Revenue Growth (%) 50% EXPENSES: Cost of Raw Materials Consumed 897 1,617 Gross Profit 1,592 2,246 Gross Mar
Slide 8: Consolidated Profit & Loss Summary
HALF YEARLY FINANCIALS Consolidated Profit & Loss Summary (All amounts are in ₹ Mn) H1FY22 H1FY23 INCOME Revenue from Operations 4,826 7,299 Other Income 105 (124) Total Revenue 4,931 7,175 Total Revenue Growth (%) 45% EXPENSES: Cost of Raw Materials Consumed 1,771 2,993 Gross Profit 3,055 4,306 Gro
Slide 9: Standalone Profit & Loss Summary
QUARTERLY FINANCIALS Standalone Profit & Loss Summary (All amounts are in ₹ Mn) Q2FY22 Q2FY23 INCOME Revenue from Operations 2,489 3,107 Other Income 62 (20) Total Revenue 2,552 3,087 Total Revenue Growth (%) 21% EXPENSES: Cost of Raw Materials Consumed 903 1,155 Gross Profit 1,586 1,951 Gross Margi
Slide 10: Standalone Profit & Loss Summary
HALF YEARLY FINANCIALS Standalone Profit & Loss Summary (All amounts are in ₹ Mn) H1FY22 H1FY23 INCOME Revenue from Operations 4,826 6,172 Other Income 105 (114) Total Revenue 4,931 6,058 Total Revenue Growth (%) 23% EXPENSES: Cost of Raw Materials Consumed 1,780 2,284 Gross Profit 3,046 3,889 Gross
Slide 11: QIP and Capex Plan Update
FINANCIALS AND OPERATIONAL UPDATES QIP and Capex Plan Update Future Plans • Raised ~₹ 5,000 mn through Qualified Institutional Strong capex plans to fund capacity expansion for newer Placement (QIP) for growth capex molecules (₹ Mn.) • Proceeds will be utilized for building multipurpose 3,000 plants
Slide 12: Fire Incident Update
FINANCIALS AND OPERATIONAL UPDATES Fire Incident Update • On September 10, 2022, fire took place in one of the manufacturing block of the factory at Unit-6 of the company • This incident led to damage of certain plant and machinery and inventory. The impact is limited which is adequately insured and
Slide 13: Growth Drivers
FINANCIALS AND OPERATIONAL UPDATES Growth Drivers Growth of Product Execution of Signed LOIs Expansion in Portfolio and Contracts Fluorination chemistry ANUPAM RASAYAN INDIA LIMITED | 12
Slide 14: Growth of Product Portfolio
FINANCIALS AND OPERATIONAL UPDATES Growth Of Product Portfolio NUMBER OF MOLECULES IN NUMBER OF MOLECULES TO R&D AND PILOT COMMERCIALISED IN FY23 90+ 7 New Strategic Custom Development Products under pipeline to be manufactured by Anupam in India: Agro: • Established Active Ingredients of originator
Slide 15: Execution of Signed LOIs and Contracts
FINANCIALS AND OPERATIONAL UPDATES Execution of Signed LOIs and Contracts Signing Quarter Segment Customer LOI/Contract Tenor (Years) Value(₹ Crores) Multinational Life Science Q1FY22 Life Science LOI 5 ₹1,100 Company Two Multinational Q1FY22 Life Science Contract 5 ₹540 Companies European Multinati
Slide 16: Expansion in Fluorination Chemistry
FINANCIALS AND OPERATIONAL UPDATES Expansion in Fluorination chemistry Details of Few Molecules out of 14 Identified Segment Revenue Focused Segments Molecules End Application Customer Potential Product A Elastomer US MNC Polymers $ 40 – 70 Mn. Semiconductor/Flame Product B Japanese MNC Retardant Pr
Slide 17: Anupam – Tanfac Integration
FINANCIALS AND OPERATIONAL UPDATES Anupam – Tanfac Integration Anupam acquired ~26% stake in Tanfac for ~₹1,530M in May'22 Backward integration with Tanfac to secure KSM Uninterrupted access to key raw materials (HF and KF) for fluorination chemistry Only Indian Producer of manufacturer of Leading p
Slide 18: Our Business
OUR BUSINESS Business Verticals and Geographies Slide 18 Key Strength: Customer Stickiness Slide 21 EHS Slide 22 Evolution of Anupam Slide 23 Strong Manufacturing Capabilities Slide 24 Leadership Team Slide 25
Slide 19: About Anupam: Company at a Glance
About Anupam COMPANY AT A GLANCE Established Custom Synthesis player Specializes in multi-step Catering to globally relevant Strong supply chain with backward with 38 years of track record synthesis undertaking complex chemical & agrochemical integrated facilities chemical reactions to produce key c
Slide 20: Business Verticals
OUR BUSINESS Business Verticals BUSINESS VERTICALS OVERVIEW HISTORICAL BUSINESS PERFORMANCE Revenue from Life Science (In ₹ Mn) Life Science Related Other Specialty 90% Q2 FY 23 2,766 Specialty Chemicals Chemicals Q1 FY 23 2,898 95% Agrochemicals Specialty Pigments (including Crop Protection) FY 22
Slide 21: Making a Mark Globally
OUR BUSINESS Making a Mark Globally MANUFACTURING CLIENTELE UNITS IN INDIA GLOBALLY (In Nos.) (In Nos.) 6* 71* REVENUE BY GEOGRAPHY EUROPE 26% EUROPE 30% EUROPE 35% EUROPE 28% INDIA 44% INDIA 38% INDIA 31% INDIA 42% SINGAPORE 11% SINGAPORE 15% SINGAPORE 13% SINGAPORE 10% Q1 Q2 FY21 FY22 JAPAN 12% JA
Slide 22: Key Strength: Customer Stickiness
OUR BUSINESS Key Strength: Customer Stickiness FEW OF OUR TOP GLOBAL CLIENTS • Long-standing relationships, clients onboarded after significant gestation period • Stringent customer audits, approvals & requirements adhered too • Dealing with top MNCs around the globe supplying them niche molecules •
Slide 23: EHS at Anupam Rasayan
OUR BUSINESS EHS at Anupam Rasayan WASTE MANAGEMENT ENVIRONMENT MANAGEMENT SAFETY COMMITED TO MAKE POSITIVE IMPACT WE BELIEVE PROTECTING THE WELL BEING COMMITTED TO CONDUCTING ALL OUR ON THE ENVIRONMENT OF OUR EMPLOYEE AND ENVIRONMENT IS OPERATION IN SAFE AND RELIABLE OUR RESPONSIBILITY MANNER • Zer
Slide 24: Evolution of Anupam
OUR BUSINESS Evolution of Anupam Phase I-Inception Phase II- The Acceleration • Fast growing • Formed partnership • Started supplying to • Awarded ‘Green • Commercialized 2 • Started working with Adama Specialty Chemical firm “Anupam Syngenta Innovation Award’ by more manufacturing • Listed on NSE a
Slide 25: Strong Manufacturing and R&D Capabilities
OUR BUSINESS Strong Manufacturing and R&D Capabilities Manufacturing prowess R&D Competencies • DSIR recognized R&D center with a team of 85 R&D professionals ~27,200 MT Manufacturing Capacity, spread over 6 manufacturing facilities • Expertise in executing complex chemistries & multi step synthesis
Slide 26: Experienced Leadership & Deep Technical Talent Pool
OUR BUSINESS Experienced Leadership & Deep Technical Talent Pool Experienced management team Our R&D talent pool Mr. Anand Desai Ms. Mona A Desai Image here Managing Director Over 30 years of experience in Image here Vice- Chairman & Whole- Time Director 85+ 100+ chemicals industry associated Over 2
Slide 27: Board of Directors
BOAD OF DIRECTORS Board of Directors Slide 27
Slide 28: Board of Directors
TEAM Board of Directors DR. KIRAN C PATEL MR. ANAND S DESAI MS. MONA A DESAI MR. MILAN THAKKAR CHAIRMAN & MANAGING DIRECTOR VICE-CHAIRMAN & NON-EXECUTIVE DIRECTOR NON-EXECUTIVE DIRECTOR WHOLE-TIME DIRECTOR • Associated with the company for past • Over 30 years of experience in • Over 20 years of exp
Slide 29: Safe Harbor
Safe Harbor Safe Harbor Certain statements in this presentation concerning our future growth prospects are forward looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company's
Slide 30: Thank You
THANK YOU CONTACT US: MR. VISHAL THAKKAR MR. RAVISH CHAUDHARY Anupam Rasayan India Ltd. investors@anupamrasayan.com MR. RAHUL THKUR MR. DIWAKAR PINGLE EY Investor Relations Rahul.thakur@in.ey.com diwakar.pingle@ey.com CORPORATE OFFICE Anupam Rasayan India Ltd. India (HQ) 8110, Sachin G.I.D.C. Estate
Anupam Rasayan India — Q2 FY2023 Earnings Presentation on 6ix